# AE-INDEX-VALIDATE-004 Validation Report

status: completed

summary: >
  Validated AE-INDEX-VALIDATE-004 as the AEGIS DS validator. The closeout
  report accurately synthesizes validator-approved evidence from tickets
  AE-INDEX-VALIDATE-001, AE-INDEX-VALIDATE-002, and AE-INDEX-VALIDATE-003,
  preserves the required interpretation boundary, and avoids causal
  overclaiming. The ticket envelope and worker completion report exist. No
  files are staged. Master may mark the epic closed in the ledger after this
  validation.

artifacts:
  - 05_Documentation/09_Epics/AE-INDEX-VALIDATE_Index_Validation/AE-INDEX-VALIDATE-004_validation_report.md

findings: []

next_recommended_role: master

## Validation Scope

- Epic: `AE-INDEX-VALIDATE`
- Ticket: `AE-INDEX-VALIDATE-004`
- Branch validated: `development-slides`
- Ticket envelope: `epics/AE-INDEX-VALIDATE/tickets/AE-INDEX-VALIDATE-004.yaml`
- Worker closeout: `05_Documentation/09_Epics/AE-INDEX-VALIDATE_Index_Validation/AE-INDEX-VALIDATE-004_Closeout_Report.md`
- Worker completion report: `05_Documentation/09_Epics/AE-INDEX-VALIDATE_Index_Validation/AE-INDEX-VALIDATE-004_worker_completion_report.md`

## Required Checks

1. Closeout report accuracy: passed. The closeout accurately summarizes ticket `001` attribution reconciliation and the limit on pure TP event-avoidance alpha claims, ticket `002` false-positive versus retained-firm diagnostics, and ticket `003` existing-output placebo approximation and limitation.
2. Final conclusion: passed. The closeout states that index results are not invalidated; the narrow alpha-from-realized-CSI-event-avoidance claim is unsupported; the defensible claim is broader distress/quality/risk screening with useful reweighting effects; and exact causal validation requires constituent-level monthly returns plus exact random-name placebo reconstruction.
3. No overclaiming: passed. The closeout frames the evidence as an economically relevant index-construction and screening result, not as proof of causal CSI event-avoidance alpha or proof against every matched placebo design.
4. Scope and must-not-touch areas: passed. Repo evidence shows no staged files. The current dirty `06_Presentations/**` and `07_CloudComputing/**` paths are unstaged and unrelated to this ticket. No `01_Code/**`, `02_Data_Input/**`, `03_Data_Output/**`, or `aegis-core` paths are modified or staged by this validation.
5. Script-run prohibition: passed based on repo evidence and worker report. The worker report states no model, index, evaluation, sensitivity, or pipeline scripts were run, and no new code/data-output artifacts from such runs were observed in the ticket scope.
6. Required artifacts: passed. The ticket envelope and worker completion report exist.
7. Staging hygiene: passed. `git diff --cached --name-status` returned no staged files.
8. Approval disposition: passed. This ticket is approved with status `completed`; master may mark the epic closed in the ledger after validation.

## Evidence Notes

- Ticket `001` source and validation reports support exact selected-row reconciliation under TP exclusion gain, FP exclusion cost, retained-stock reweighting effect, transaction-cost effect, and compounding/geometric adjustment. They also state that near-zero TP gain weakens a pure event-avoidance interpretation without invalidating index alpha.
- Ticket `002` source and validation reports support the closeout's diagnostic summary: false positives underperform retained true negatives in six of eight selected rows, but underperform the retained strategy portfolio in only one of eight rows; the interpretation remains non-causal.
- Ticket `003` source and validation reports support the closeout's placebo summary: six of eight selected CSI rows exceed the approved approximation p95 and maximum, but the approximation is not an exact random-name exclusion null.

## Residual Notes

- The ledger currently records `AE-INDEX-VALIDATE-004` as `worker_complete`. Per the ticket acceptance criteria, master should add the epic closure ledger event after validator approval.
- Existing unstaged presentation and cloud-validation worktree changes are outside this ticket's approved write scope and were treated as non-blocking because they are unstaged and unrelated.
